The clinical characteristics and prognosis of elderly patients with lung cancer diagnosed in Daegu and Gyeongsangbukdo

Tuberculosis and Respiratory Diseases

Volumn 65, Issue 1, 2008, Pages 15-22

  Hyun, Sook Kim ^a   Dae, Sung Hyun ^a   Kyung, Chan Kim ^a   Sang, Chae Lee ^a   Tae, Hoon Jung ^b   Jae, Yong Park ^b   Chang, Ho Kim ^b   Seung, Ick Cha ^b   Kwan, Ho Lee ^c   Jin, Hong Chung ^c   Kyeong, Cheol Shin ^c   Young, June Jeon ^d   Seong, Beom Han ^d   Won, Il Choi ^d   Yeun, Jae Kim ^e   Chi, Young Chung ^e   Geon, Il Lim ^f  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Keimyung University   (South Korea)

^e Rheumatology Center at Daegu Fatima Hospital   (South Korea)

^f Soonchunhyang University   (South Korea)

Author keywords

Elderly patients; Lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPNEA; FEMALE; GERIATRIC PATIENT; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM;

EID: 49149102310     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2008.65.1.15     Document Type: Article

References (17)

1. Korea National Statistical Office. Statistics on the aged. Daejeon: Korea National Statistical Office; 2005.
2. Gridelli C, Maione P, Comunale D, Rossi A. Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer. Cancer Control 2007;14:57-62.
3. Korean Cancer Registry. Annual report of the Korean Cancer Registry. Seoul: Ministry of Health and Welfare; 2002.
4. Ryu JS, Lee HJ, Leem JH, Kim L, Lee KH, Cho JH, et al. Clinical characteristics of primary lung cancer patients in a tertiary hospital. Tuberc Respir Dis 2006;60:321-9.
5. Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, Ryu JS, et al. National survey of lung cancer in Korea, 2005. J Lung Cancer 2007;6:67-73.
6. Woo CM, Kim SY, Lee SA, Oh HJ, Bae SH, Ryoo HM, et al. Paclitaxel for elderly patients with advanced NSCLC. Korean J Med 2006;70:183-9.
7. Gridelli C, Penone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003;95:362-72.
8. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003;21:3201-6.
9. Altundag O, Stewart DJ, Fossella FV, Ayers GD, Wei W, Zhou X, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol 2007;2:141-6.
10. Spaggiari L, Scanagatta P. Surgery of non-small cell lung cancer in the elderly. Cun Opin Oncol 2007;19:84-91.
11. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
12. Korea National Statistical Office. Death cause statistics of Korea. Daejeon: Korea National Statistical Office; 2005.
13. Scienticfic Committee of Korean Academy of Tuberculosis and Respiratory Diseases. The national survey of lung cancer in Korea. Tuberc Respir Dis 1999;46:455-65.
14. Lee-Chiong TL Jr, Matthay RA. Lung cancer in the elderly patient. Clin Chest Med 1993;14:453-78.
15. Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax 1996;51:564-8.
16. Montella M, Gridelli C, Crispo A, Scognamiglio F, Ruffolo P, Gatani T, et al. Has lung cancer in the elderly different characteristics at presentation? Oncol Rep 2002;9:1093-6.
17. Zagonel V, Pinto A, Senaino D, Babare R, Sacco C, Merola MC, et al. Lung cancer in the elderly. Cancer Treat Rev 1994;20:315-29.